WGS
GeneDx Holdings Corp.
NASDAQ · USHealthcareMedical - Healthcare Information Services
$60.65-4.46%
Price as of Jul 20, 2026
WGS growth
GeneDx Holdings Corp. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +34.1%
- EBITDA
- —
- EBIT
- —
- EPS
- -84.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
- Revenue
- +40.0%
- EBITDA
- —
- EPS
- +153.4%
Three-year CAGR
- Revenue
- +22.1%
- EBITDA
- +124.0%
- EBIT
- +49.2%
- Net income
- +59.8%
- EPS
- +62.4%
- Free cash flow
- +142.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.